BioArctic receives grant for collaborative research to improve immunotherapy for CNS disorders April 4, 2019
ViGenCell opens enrollment in phase II trial of VT-EBV-N for EBV-positive patients with ENKL April 4, 2019
Theralase's phase Ib study of TLD-1433 shows 66% CR at therapeutic dose 360 days post treatment April 4, 2019
Discovery and characterization of a novel selective LMP7 inhibitor for multiple myeloma April 4, 2019
RSS